Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Surgery Today
Erschienen in: Surgery Today 5/2014

01.05.2014 | Review Article

Regulating surgical oncotaxis to improve the outcomes in cancer patients

verfasst von: Toshihiro Hirai, Hideo Matsumoto, Hisako Kubota, Yoshiyuki Yamaguchi

Erschienen in: Surgery Today | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Excessive surgical stress and postoperative complications cause a storm of perioperative cytokine release, which has been shown to enhance tumor metastasis in experimental models. We have named this phenomenon “surgical oncotaxis”. The mechanisms that underpin this process are thought to be excessive corticosteroid secretion, coagulopathy in the peripheral vasculature, immune suppression and excessive production of reactive oxygen species. Nuclear factor-kappa B (NFkB) activation plays a key role in these mechanisms. Minimally invasive surgical techniques should be used, and postoperative complications should be avoided whenever possible to lessen the impact of surgical oncotaxis. Furthermore, there may be a role for a small preoperative dose of corticosteroid or the use of free radical scavengers in the perioperative period. Recently, there has been a great deal of interest in omega-3 fatty acid, because it regulates NFkB activation. The use of multimodal treatments that regulate surgical oncotaxis may be as important as chemotherapy for determining the outcome of patients with cancer undergoing surgery.
Literatur
1.
Hattori T, Hamai Y, Ikeda H, Harada T, Ikeda T. Enhancing effect of thoracotomy on tumor growth in rats. Gann. 1978;69:401–6.PubMed
2.
Hattori T, Hamai Y, Takiyama W, Hirai T, Ikeda T. Enhancing effect of thoracotomy on tumor growth in rats with special reference to the duration and timing of the operation. Gann. 1980;71:280–4.PubMed
3.
Hirai T, Matsumoto H, Yamashita Y, Urakami A, Iki K, Yamamura M, et al. Surgical oncotaxis—excessive surgical stress and postoperative complications contribute to enhancing tumor metastasis, resulting in a poor prognosis for cancer patients. Ann Thorac Cardiovasc Surg. 2005;11:4–6.PubMed
4.
Albert D, Zeidman I. Relation of glucocorticoid activity of steroids to number of metastases. Cancer Res. 1962;22:1297–300.PubMed
5.
Zeidman I. The fate of circulating tumor cells. A mechanism of cortisone action in increasing metastases. Cancer Res. 1962;22:501–3.PubMed
6.
Kodama M, Kodama T. Enhancing effect of hydrocortisone on hematogenous metastasis of Ehrlich ascites tumor in mice. Cancer Res. 1975;35:1015–21.PubMed
7.
Hirai T. Experimental studies on tumor enhancing effect of operative stress with special reference to the participation of corticosteroid (in Japanese). Hiroshimadaigaku Igaku Zasshi (Med J Hiroshima Univ). 1985;33:871–82.
8.
Glasner A, Avraham R, Rosenne E, Benish M, Zmora O, Shemer S, et al. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J Immunol. 2010;184:2449–57.PubMedCrossRef
9.
Kakkar AK, Lorenzo F, Pineo GF, Williamson RCN. Venous thromboembolism and cancer. Bailliere’s Clin Haematol. 1998;11:675–87.CrossRef
10.
Stouthard JML, Levi M, Hack CE, Veenhof CHN, Romijn HA, Sauerwein HP, et al. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost. 1996;76:738–42.PubMed
11.
Nawroth PP, Stern DM. Tumor necrosis factor/cachectin-induced modulation of endothelial cell hemostatic properties. Onkologie. 1987;10(254):258.
12.
Suemasu K, Ishikawa S. Inhibitive effect of heparin and dextran sulfate on experimental pulmonary metastases. Gann. 1970;61:125–30.PubMed
13.
Rak J, Milsom C, May L, Klement P, Yu J. Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy. Semin Thromb Hemost. 2006;32:54–7.PubMedCrossRef
14.
Kakkar AK, Lemoine NR, Scully MF, Tebbutt S, Williamson RC. Tissue factor expression correlate with histological grade in human pancreatic cancer. Br J Surg. 1995;82:1101–4.PubMedCrossRef
15.
Nakasaki T, Wada H, Shigemori C, Miki C, Gabazza EC, Mobori T, et al. Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol. 2002;69:247–54.PubMedCrossRef
16.
Sawada M, Miyake S, Ohdama S, Mstsubara O, Masuda S, Yakumaru K, et al. Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis. Br J Cancer. 1999;79:472–7.PubMedCentralPubMedCrossRef
17.
Poon RT, Lau CP, Ho JW, Yu WC, Fan ST, Wong J. Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma. Clin Cancer Res. 2003;9:5339–45.PubMed
18.
Takagi T, Sakakura C, Kin S, Nakase Y, Fukuda K, Shimomura K, et al. Dextran sulfate suppresses cell adhesion and cell cycle progression of melanoma cells. Anticancer Res. 2005;25:895–902.PubMed
19.
DeFeo K, Hayes C, Chernick M, Ryn JV, Gilmour SK. Use of dabigastran etexilate to reduce breast cancer progression. Cancer Biol Ther. 2010;10:1001–8.PubMedCrossRef
20.
Dolovich LR, Ginsberg JS, Douketis JD, Holbrook AM, Cheah G. A meta-analysis comparing low-molecular-weight heparin with unfractioned heparin in the treatment of venous thromboembolism. Arch Intern Med. 2000;160:181–8.PubMedCrossRef
21.
Altinbas M, Coskun HS, Er O, Ozkan M, Eser B, Unal A, et al. A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer. J Thromb Haemost. 2004;2:1266–71.PubMedCrossRef
22.
Kakkar AK, Levine MN, Kadziola Z, Lemoine NR, Low V, Patel HK, et al. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS). J Clin Oncol. 2004;22:1944–8.PubMedCrossRef
23.
Kirstein JM, Graham KC, Mackenzie LT, Johnston DE, Martin LJ, Tuck AB, et al. Effect of anti-fibrinolytic therapy on experimental melanoma metastasis. Clin Exp Metastasis. 2009;26:121–31.PubMedCrossRef
24.
Nadir Y, Brenner B. Heparanase procoagulant activity. Thromb Res. 2012;129:576–9.
25.
Ogawa K, Hirai M, Katsube T, Murayama M, Hamaguchi K, Shimakawa T, et al. Suppression of cellular immunity by surgical stress. Surgery. 2000;127:329–36.PubMedCrossRef
26.
Vallina VL, Velasco JM. The influence of laparoscopy on lymphocyte subpopulations in the surgical patient. Surg Endosc. 1996;10:481–4.PubMedCrossRef
27.
Shafirb M, Bekesi JG, Papatestas A, Slater G, Aufses AH Jr. Preoperative and postoperative immunological evaluation of patients with colorectal cancer. Cancer. 1980;46:700–5.CrossRef
28.
Cristaldi M, Rovati M, Elli M, Gerlinzani S, Lesma A, Barzarotti L, et al. Lymphocyte subpopulation changes after open and laparoscopic cholecystectomy: a prospective and comparative study on 38 patients. Surg Laparosc Endosc. 1997;7:255–61.PubMedCrossRef
29.
Leaver HA, Craig SR, Yap PL, Walker WS. Lymphocyte responses following open and minimally invasive thoracic surgery. Eur J Clin Invest. 2000;30:230–8.PubMedCrossRef
30.
Ben-Eliyohu S, Page GG, Yirmaiya R, Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer. 1999;80:880–8.CrossRef
31.
Ahlers O, Nachtigall I, Lenze J, Goldmann A, Schulte E, Hohne C, et al. Intraoperative thoracic epidural anesthesia attenuates stress-induced immunosuppression in patients undergoing major abdominal surgery. Br J Anaesth. 2008;101:781–7.PubMedCrossRef
32.
Mafdy AM, Galley HF, Abdel-Wahed MA, el-Korny KF, Sheta SA, Webster NR. Differential modulation of interleukin-6 and inter-leukin-10 by diclofenac in patients undergoing major surgery. Br J Anaesth. 2002;88:797–802.CrossRef
33.
Dithmar S, Rusciano D, Lynn MJ, Lawson DH, Armstrong CA, Grossniklaus HE. Neoadjuvant interferone alfa-2b treatment in a murine model for metastatic ocular melanoma: a preliminary study. Arch Ophthalmol. 2000;118:1085–9.PubMedCrossRef
34.
Gallagher WJ, Dubinett SM, Hoover HC Jr, Kradin RL. Efficacy of adjuvant interleukin-2 after excision of BALB/c fibrosarcoma. Surgery. 1989;106:120–5.PubMed
35.
Caprotti R, Bribio F, Fumagalli L, Nobili C, Degrate L, Lissoni P, et al. Free-from-progression period and overall short preoperative immunotherapy with IL-2 increases the survival of pancreatic cancer patients treated with macroscopically radical surgery. Anticancer Res. 2008;28:1951–4.PubMed
36.
Bravio F, Lissoni P, Fumagalli L, Girlando M, Marsili MT, Nespoli A, et al. Pre-operative IL-2 immunoprophylaxis of cancer recurrence: long term clinical results of a phase II study in radically operable colorectal cancer. Oncol Rep. 1999;6:1205–7.
37.
Toge T, Hirai T, Takiyama W, Hattori T. Effects of surgical stress on natural killer activity, proliferative response of spleen cells and cytostatic activity of lung macrophages in rats. Gann. 1981;72:790–4.PubMed
38.
Hattori T, Hamai Y, Ikeda T, Takiyama W, Hirai T, Miyoshi Y. Inhibitory effects of immunopotentiators on the enhancement of lung metastases induced by operative stress in rats. Gann. 1982;73:132–5.PubMed
39.
Yamaguchi Y, Hihara J, Hironaka K, Ohshita A, Okita R, Okawaki M, et al. Postoperative immunosuppression cascade and immunotherapy using lymphokine-activated killer cells for patients with esophageal cancer: possible application for compensatory anti-inflammatory response syndrome. Oncol Rep. 2006;15:895–901.PubMed
40.
Adamson IYR, Young L, Orr FW. Tumor metastasis after hyperoxic injury and repair of the pulmonary endothelium. Lab Invest. 1987;57:71–7.PubMed
41.
Nonaka Y, Iwagaki H, Kimura T, Fuchimoto S, Orita K. Effect of reactive oxygen intermediates on the in vitro invasive capacity of tumor cells and liver metastasis in mice. Int J Cancer. 1993;54:983–6.PubMedCrossRef
42.
ten Kate M, van der Wal JB, Sluiter W, Hofland LJ, Jeekel J, Sonneveld P. The role of superoxide anions in the development of distant tumour recurrence. Br J Cancer. 2006;95:1497–503.PubMedCentralPubMedCrossRef
43.
Mongaret C, Alexandre J, Thomas-Schoemann A, Bermudez E, Cherau C, Nicco C, et al. Tumor invasion induced by oxidative stress is dependent on membrane ADAM 9 protein and its secreted form. Int J Cancer. 2011;129:791–8.PubMedCrossRef
44.
Hirai T, Yoshimoto A, Iwata T, Yamashita Y, Kuwahara M, Toge T. Enhancing effect of thoraco-laparotomy on liver metastasis and the role played by active oxygen in its mechanism. Jpn J Surg. 1997;27:1040–5.
45.
Hyoudou K, Nishikawa M, Kobayashi Y, Ikemura M, Yamashita F, Hashida M. SOD derivatives prevent metastatic tumor growth aggravated by tumor removal. Clin Exp Metastasis. 2008;25:531–6.PubMedCrossRef
46.
Sun Y-F, Yang X-R, Zhou J, Qiu S-J, Fan J, Xu Y. Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance. J Cancer Res Clin Oncol. 2011;137:1151–73.PubMedCrossRef
47.
Rahbari NN, Aigner M, Thorlund K, Mollberg N, Motschall E, Jensen K, et al. Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology. 2010;138:1714–26.PubMedCrossRef
48.
Qu Y, Wang J, Ray PS, Guo H, Huang J, Shin-Shim M, et al. Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-kB signaling. J Clin Invest. 2011;121:212–25.PubMedCentralPubMedCrossRef
49.
Tsukioka T, Nishiyama N, Iwata T, Nagano K, Tei K, Suehiro S. Preoperative serum oxidative stress marker as a strong indicator of nodal involvement in clinical stage I lung adenocarcinoma. Int J Clin Oncol. 2012;17:250–5.PubMedCrossRef
50.
Brokelman WJ, Lansvert M, Borel Rinkes IH, Kinkenbijil JH, Reijinen MM. Peritoneal change due to laparoscopic surgery. Surg Endosc. 2011;25:1–9.PubMedCentralPubMedCrossRef
51.
Ishikawa M, Nishioka M, Hanaki N, Miyauchi T, Kashiwagi Y, Ioki H, et al. Perioperative immune response in cancer patients undergoing digestive surgeries. World J Surg Oncol. 2009;7:7.PubMedCentralPubMedCrossRef
52.
Brune IB, Wilke W, Hensler T, Feussner H, Holzmann B, Siewert JR, et al. Normal T lymphocyte and monocyte function after minimally invasive surgery. Surg Endosc. 1998;12:1020–4.PubMedCrossRef
53.
Kloosterman T, von Blomberg BM, Borgstein P, Cuesta MA, Scheper RJ, Meijer S. Unimpaired immune functions after laparoscopic cholecystectomy. Surgery. 2006;139:39–45.CrossRef
54.
55.
Eisold S, Mehrabi A, Konstantinidis L, Mieth M, Hinz U, Kashfi A, et al. Experimental study of cardiorespiratory and stress factors in esophageal surgery using robot-assisted thoracoscopic or open thoracic approach. Arch Surg. 2008;143:156–63.PubMedCrossRef
56.
Amin AT, Shiraishi N, Ninomiya S, Tajima M, Inomata M, Kitano S. Increased mRNA expression of epidermal growth factor receptor, human epidermal receptor, and survivin in human gastric cancer after the surgical stress of laparotomy versus carbon dioxide pneumoperitoneum in a murine model. Surg Endosc. 2010;24:1427–33.PubMedCrossRef
57.
Tsujimoto H, Takahata R, Nomura S, Yaguchi Y, Kumano I, Matsumoto Y, et al. Video-assisted thoracoscopic surgery for esophageal cancer attenuates postoperative systemic responses and pulmonary complications. Surgery. 2012;151:667–73.PubMedCrossRef
58.
Walker WS, Leaver HA. Immunologic and stress responses following video-assisted thoracic surgery and open pulmonary lobectomy in early stage lung cancer. Thorac Surg Clin. 2007;17:241–9.PubMedCrossRef
59.
Biere SS, van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Garcia JR, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomized controlled trial. Lancet. 2012;379:1887–92.PubMedCrossRef
60.
Rizk NP, Bach PB, Schrag D, Bains MS, Turnbull AD, Karpeh M, et al. The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg. 2004;198:42–50.PubMedCrossRef
61.
Hu Y, Zheng B, Rong T-H, Fu J-H, Zhu Z-H, Yang H, et al. Prognostic analysis of the patients with stage-III esophageal squamous cell carcinoma after radical esophagectomy. Chin J Cancer. 2010;29:178–83.PubMedCrossRef
62.
Shimada H, Okazumi S, Matsubara H, Nabeya Y, Shiratori T, Hayashi H, et al. Is the surgical stress associated with worse survival in patients with esophageal cancer?—analysis of colon substitution for 37 patients with remnant stomach. Hepatogastroenterology. 2007;54:791–5.PubMed
63.
Sierzega M, Kolodziejczyk P, Kulig J. Impact of anastomotic leakage on long-term survival after total gastrectomy for carcinoma of the stomach. Br J Surg. 2010;97:1035–42.PubMedCrossRef
64.
Toshihiro H, Hihara J, Inoue H, Toge T, Inoue Y, Sakaue T. The effect of radical scavenger EPC-K1 and methylprednisolone on reactive substances after surgery (in Japanese). Nippon Syoukakigekagakkaishi (Jpn J Gastroenterol Surg). 2001;34:323–8.
65.
Sayama J, Shineha R, Yokota K, Hirayama K, Higuchi N, Ohe H, et al. Control of the excessive reaction after surgery for esophageal carcinoma with preoperative administration of the cortico-steroids (in Japanese). Nippon Syoukakigekagakkaishi (Jpn J Gastroenterol Surg). 1994;27:841–8.
66.
Ueda H, Hirakawa H, Shineha R, Sayama J, Nishihira T, Mori S. Postoperative changes of serum IL-6 production and preventive effects of methylprednisolone for mouse experimental surgical stress (in Japanese). Nippon Syoukakigekagakkaishi (Jpn J Gastroenterol Surg). 1994;27:2191.
67.
Raimondi AM, Guimaraes HP, Amaral JLG, Leal PHR. Perioperative glucocorticoid administration for prevention of systemic organ failure in patients undergoing esophageal resection for esophageal carcinoma. Sao Paulo Med J. 2006;124:112–5.PubMedCrossRef
68.
Shimada H, Ochiai T, Okazumi S, Matsubara H, Nabeya Y, Miyazawa Y, et al. Clinical benefits of steroid therapy on surgical stress in patients with esophageal cancer. Surgery. 2000;128:791–8.PubMedCrossRef
69.
Shimada H, Okazumi S, Matsubara H, Nabeya Y, Hayashi H, Shiratori T, et al. Effects of steroid therapy on postoperative course and survival of patients with thoracic esophageal carcinoma. Esophagus. 2004;1:89–94.CrossRef
70.
Nishizaki C, Nishikawa M, Yata T, Yamada T, Takahashi Y, Oku M, et al. Inhibition of surgical trauma-enhanced peritoneal dissemination of tumor cells by human catalase derivatives in mice. Free Radic Biol Med. 2011;51:773–9.PubMedCrossRef
71.
By Ho, Wu YM, Chang KJ, Pan TM. Dimerumic acid inhibits SW620 cell invasion by attenuating H2O2-mediated MMP-7 expression via JNK/C-Jun and ERK/C-Fos activation in an AP-1-dependent manner. Int J Biol Sci. 2011;7:869–80.
72.
O’Leary DP, Bhatt L, Woolley JF, Gough DR, Wang JH, Cotter TG, et al. TLR-4 signalling accelerates colon cancer cell adhesion via NF-kB mediated transcriptional up-regulation of Nos-1. PLoS ONE. 2012;7:e44176.PubMedCentralPubMedCrossRef
73.
Yuksel M, Okajima K, Uchiba M, Okabe H. Gabexate mesilate, a synthetic protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappaB and activator protein-1 in human monocytes. J Pharmacol Exp Ther. 2003;305:298–305.PubMedCrossRef
74.
Ohashi I, Nishijima J, Murata A, Tada H, Kato H. Inhibitory effect of a synthetic protease inhibitor (gabexate mesilate) on the respiratory burst oxidase in human neutrophils. J Biochem. 1995;118:1001–6.PubMedCrossRef
75.
Jung SE, Yun IJ, Youn YK, Lee JE, Ha J, Noh DY, et al. Effect of protease inhibitor on ischemia–reperfusion injury to rat liver. World J Surg. 1999;23:1027–31.PubMedCrossRef
76.
Goldfarb Y, Shapiro H, Singer P, Kalderon Y, Levi B, Glasner A, et al. Fish oil attenuates surgery-induced immunosuppression, limits post-operative metastatic dissemination and increases long-term recurrence-free survival in rodents inoculated with cancer cells. Clin Nutr. 2012;31:396–404.PubMedCrossRef
77.
Kontogiannea M, Gupta A, Ntanios F, Graham T, Jones P, Meterissian S. Omega-3 fatty acids decrease endothelial adhesion of human colorectal carcinoma cells. J Surg Res. 2000;92:201–5.PubMedCrossRef
78.
Gutt CN, Brinkmann L, Mehrabi A, Fonouni H, Muller-Stich BP, Vetter G, et al. Dietary omega-3-polyunsaturated fatty acids prevent the development of metastasis of colon carcinoma in rat liver. Eur J Nutr. 2007;46:279–85.PubMedCrossRef
79.
80.
Ghosh-Choudhury T, Mandal CC, Woodruff K, Clair PS, Fernandes G, Choudhury GG, et al. Fish oil targets PTEN to regulate NFκB for downregulation of anti-apoptotic genes in breast tumor growth. Breast Cancer Res Treat. 2009;118:213–8.PubMedCentralPubMedCrossRef
81.
Zhao Y, Joshi-Barve S, Barve S, Chen LH. Eicosapentaenoic acid prevents LPS-induced TNF-α expression by preventing NF-κB activation. J Am Coll Nutr. 2004;23:71–8.PubMedCrossRef
82.
Mishra A, Chaudhary A, Sethi S. Oxidized omega-3 fatty acids inhibit NF-κB activation via a PPARα-dependent pathway. Arterioscler Thromb Vasc Biol. 2004;24:1621–7.PubMedCrossRef
83.
Jho DH, Cole SM, Lee EM, Espat NJ. Role of omega-3 fatty acid supplementation in inflammation and malignancy. Integr Cancer Ther. 2004;3:98–111.PubMedCrossRef
84.
Wang J, Yu JC, Kang WM, Ma ZQ. Superiority of a fish oil-enriched emulsion to medium-chain triacylglycerols/long-chain triacylglycerols in gastrointestinal surgery patients: a randomized clinical trial. Nutrition. 2012;28:623–9.PubMedCrossRef
Metadaten
Titel
Regulating surgical oncotaxis to improve the outcomes in cancer patients
verfasst von
Toshihiro Hirai
Hideo Matsumoto
Hisako Kubota
Yoshiyuki Yamaguchi
Publikationsdatum
01.05.2014
Verlag
Springer Japan
Erschienen in
Surgery Today / Ausgabe 5/2014
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-013-0627-0

Weitere Artikel der Ausgabe 5/2014

Surgery Today 5/2014 Zur Ausgabe

Original Article

Adhesive strength of ethyl-2-cyanoacrylate tissue adhesive: how strong is it?

Case Report

A large presacral tailgut cyst with a carcinoid tumor in a male: report of a case

Case Report

Three-year survival after surgery for primary malignant pericardial mesothelioma: report of a case

Original Article

Atrial fibrillation after esophageal cancer surgery: an analysis of 207 consecutive patients

Original Article

Long-term outcome of laparoscopic-assisted right-hemicolectomy with D3 lymphadenectomy versus open surgery for colon carcinoma

Original Article

Is a small-bore catheter efficient for most pleural pathologies?

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 49 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Neu im Fachgebiet Allgemeinmedizin

Wie der Klimawandel gefährliche Pilzinfektionen begünstigt

24.05.2024 Candida-Mykosen Nachrichten

Dass sich invasive Pilzinfektionen in letzter Zeit weltweit häufen, liegt wahrscheinlich auch am Klimawandel. Ausbrüche mit dem Hefepilz Candida auris stellen eine zunehmende Gefahr für Immungeschwächte dar – auch in Deutschland.

Das sind die führenden Symptome junger Darmkrebspatienten

23.05.2024 Leitsymptome in der Hausarztpraxis Nachrichten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

Chronische Verstopfung: „Versuchen Sie es mit grünen Kiwis!“

22.05.2024 Obstipation Nachrichten

Bei chronischer Verstopfung wirken Kiwis offenbar besser als Flohsamenschalen. Das zeigen die Daten aus einer randomisierten Studie, die der Gastroenterologe Oliver Pech beim Praxis-Update vorstellte.

So häufig greift rheumatoide Arthritis auf Organe über

21.05.2024 Rheumatoide Arthritis Nachrichten

Im Verlauf von rheumatoider Arthritis entwickeln viele Patienten extraartikuläre Manifestationen. Schwedische Forscher haben sich mit der Inzidenz und den Risikofaktoren befasst.

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise